FDA in a Shutdown: The Plan Still Matters
This article was originally published in RPM Report
Executive Summary
A government shutdown was averted but not until federal agency’s were forced to communicate their shutdown plans to employees and the public. Those plans may have a lingering impact—and not just because the threat of a shutdown is sure to arise again.
You may also be interested in...
FDA’s Shutdown Plan: Some User Fee Services Would Continue; Routine Inspections Would Not
The agency would retain 8,180 staff members, about 55% of its total, mostly because they could be “paid from carryover funding.”
FDA Leadership Changes Reflect Budgetary, Scientific Challenges
FDA has a new chief operating officer and medical officer. The appointments reflect the challenges of a lean budget and calls for a chief scientist from the Institute of Medicine.
PDUFA IV: You Can't Always Get What You Want
Former Senate HELP Committee FDA counsel Steven Irizarry looks ahead at the reauthorization of PDUFA and what drug companies should expect in the latest round of negotiations.